In a boost to India-Saudi Arabia ties, Riyadh will be receiving 3 million AstraZeneca Covid-19 vaccine doses from Pune-based Serum Institute of India. 

Sindhudesh: Pakistan’s New Headache — Why Sindhis Want To Secede From Pakistan & Create A Separate Country?

Chief Executive of the Serum Institute of India (SII) Adar Poonawalla told Reuters the doses destined for Saudi Arabia would be shipped in a week or 10 days. SII is also supplying South Africa with 1.5 million doses at the same price of $5.25 each on behalf of AstraZeneca.

Recently, both Saudi Arabia and India have reiterated how the strategic and defense ties between the two countries are witnessing an “upward trajectory”. Writing for Arab News N.

Ram Prasad, deputy chief of mission at the Indian Embassy in Riyadh, says the two countries are ascending powers and major players in their respective regions and are natural partners in addressing the various security challenges confronting the region.

He recalls the signing of the landmark ‘Riyadh Declaration’ during the visit of then-Indian Prime Minister Dr. Manmohan Singh in 2010, which raised the relationship to a strategic partnership. Since then, the two sides have undertaken several measures to further promote the partnership.

The two sides had set-up a Joint Committee on Defense Cooperation (JCDC) to identify areas for cooperation in the field of defense. During the JCDC meetings, there were discussions on training and capacity building, intelligence exchange, maritime security, and the promotion of defense industries, Prasad highlights.

Saudi Arabia’s ambassador to India, Dr. Saud bin Mohammed Al Sati, has also penned a piece for the Indian news agency PTI, boasting the ties between New Delhi and Riyadh. Stressing upon the ties, he says, “The strategic partnership between Saudi Arabia and India is witnessing a new dawn”.

He notes, it is a relationship that has grown on the strong foundations of shared culture and thrived on opportunities for a strategic partnership. Bilateral trade between India and Saudi Arabia has increased in the past two years from $27 billion in 2018-19 to $34 billion in 2019-2020.

The Saudi diplomat goes on to highlight how from the supply of crude oil and refined products to a comprehensive energy partnership focusing on investment and joint ventures in petrochemical complexes, both countries are working on further strengthening this relationship.

Apart from what the two diplomats wrote in the praise of the bilateral ties, which came out at the same time, there are other factors that seem to have made the relations stronger than before. Indian army chief General Manoj Mukund Naravane had visited Saudi Arabia in December 2020 on a “historic” trip.

The visit was aimed at “strengthening the country’s strategic and defense cooperation” with the two nations. Saudi Arabia is India’s fourth-largest trading partner after China, the United States, and Japan.

Mohammed Al Sati points out that the Indian government “permitted hundreds of healthcare professionals to travel back to Saudi Arabia, to join their workplaces in Saudi hospitals and medical institutions, which supported the Kingdom’s domestic efforts against Covid-19”.

It is pertinent to mention that the Gulf region is home to 8.5 million Indian workers, with more than 2.7 million living in Saudi Arabia.


Author’s Profile

Follow EurAsian Times on Google

The post Booster Shot For India-Saudi Arabia Ties As Riyadh To Get 3 Million Doses From Pune Vaccine Maker appeared first on Latest Asian, Middle-East, EurAsian, Indian News.

Leave a Reply

Your email address will not be published. Required fields are marked *

Translate »
Legal Notice: Views expressed in articles published in www.ebusinessbrief.com are those of the authors and www.ebusinessbrief.com or its owners take no responsibility regarding the same. Advertisements in www.ebusinessbrief.com are published for information of the subscribers. www.ebusinessbrief.com does not authenticate, endorse or guarantee any of the products or services or claims made by the Advertisers. Readers are advised to themselves verify the details. No part of this publication may be reproduced by any means without prior written permission from the Editor. Permission is normally granted wherever sufficient acknowledgement is given to www.ebusinessbrief.com.